We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock
VAXX

Delisted

VAXX was delisted on the 8th of May, 2024.

Back to rankings

58 hedge funds and large institutions have $8.73M invested in Vaxxinity, Inc. Class A Common Stock in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less funds holding

Funds holding: 59 → 58 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

20% less capital invested

Capital invested by funds: $10.9M → $8.73M (-$2.15M)

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
15
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SAS
Stelac Advisory Services
New York
+$102K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$26.5K
3
Renaissance Technologies
Renaissance Technologies
New York
+$25.4K
4
TI
Tidal Investments
Wisconsin
+$23.6K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$15.1K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$289K
2
Bank of America
Bank of America
North Carolina
-$193K
3
Citadel Advisors
Citadel Advisors
Florida
-$67.5K
4
BlackRock
BlackRock
New York
-$65.9K
5
Barclays
Barclays
United Kingdom
-$20.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
AWM
51
Avior Wealth Management
Nebraska
$1.48K +$4 +6 +0.3%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$1K -$9.27K -12,784 -93%
AB
53
Amalgamated Bank
New York
$1K -$3.33K -4,597 -76%
FDCDDQ
54
Federation des caisses Desjardins du Quebec
Quebec, Canada
$592 – – –
EBA
55
Eagle Bay Advisors
New York
$508 – – –
SSB
56
Sandy Spring Bank
Maryland
$72 – – –
RF
57
Robinswood Financial
Washington
$39 – – –
Citadel Advisors
58
Citadel Advisors
Florida
– -$67.5K -79,444 Closed
HCM
59
Hollencrest Capital Management
California
– -$17K -20,000 Closed
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
– -$12.6K -14,766 Closed
TSS
61
Two Sigma Securities
New York
– -$9.93K -11,684 Closed
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
– -$9.41K -11,074 Closed
Kayne Anderson Rudnick Investment Management
63
Kayne Anderson Rudnick Investment Management
California
– -$6.03K -7,089 Closed
GWS
64
Glassman Wealth Services
Virginia
– -$2.03K -2,386 Closed
ASN
65
Advisory Services Network
Georgia
– -$510 -600 Closed
CAL
66
Capital Advisors Ltd
Ohio
– +$45 +62 New
1 2
3

VAXX Hedge Fund Activity: Q1 2024 in Review

58 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q1 2024, worth a combined $8.73M — down 20% from $10.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of VAXX and 7 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 11 added.

The largest buyer was Stelac Advisory Services, opening a new position worth an estimated $102K. The largest seller was Morgan Stanley, cutting an estimated $289K.

  • 58 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q1 2024, down from 59 in Q4 2023.
  • Funds reported $8.73M of Vaxxinity, Inc. Class A Common Stock stock for Q1 2024, down 20% quarter-over-quarter.
  • 7 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q1 2024 and 8 closed out, a net change of -1 holder.
  • The largest Vaxxinity, Inc. Class A Common Stock buyer in Q1 2024 was Stelac Advisory Services, an estimated $102K added.
  • The largest Vaxxinity, Inc. Class A Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $289K sold.

Based on aggregated 13F filings for Q1 2024.